17.73 (-%)
As of Nov 22, 2024
Source:
Novocure Ltd is a global oncology company with a proprietary platform technology called Tumor Treating Fields ("TTFields"), which are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. Our key priorities are to drive commercial adoption of Optune and Optune Lua, our commercial TTFields devices, and to advance clinical and product development programs intended to extend overall survival in some of the most aggressive forms of cancer.
Country | United States |
Headquarters | st. helier |
Phone Number | 44 (0)15 3475 6700 |
Industry | manufacturing |
CEO | Asaf Danziger |
Website | www.novocure.com |